Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal desmopressin to reduce intraoperative blood loss in open rhinoplasty
IRCT20200708048051N3Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Feb 2021
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of desmopressin, sponsored by Guilan University of Medical Sciences. Primary endpoints: Intraoperative blood loss and Quality of the surgical field. Started Feb 2021; status: completed.
02
Drugs
desmopressin
Beyond the preview
Go deeper on IRCT20200708048051N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200708048051N3.